Nateglinide and electrolyte imbalance Patient Reports February 09, 2010

Nateglinide Side Effects Report #5595578-9
Nateglinide side effect was reported by a Physician from on Jan 09, 2008. Male patient, 88 years of age, weighting 130.1 lb, was diagnosed with glucose tolerance impaired, cardiovascular disorder and was treated with Nateglinide. After drug was administered, patient experienced the following side effects: electrolyte imbalance. Nateglinide dosage: unknown. During the same period patient was treated with VALSARTAN. Patient was hospitalized. Patient recovered.

Nateglinide Side Effects Report #5602160-3
Nateglinide side effect was reported by a Physician from SPAIN on Jan 16, 2008. Male patient, 88 years of age, weighting 130.1 lb, was diagnosed with glucose tolerance impaired, cardiovascular disorder and was treated with Nateglinide. After drug was administered, patient experienced the following side effects: blood sodium decreased, electrolyte imbalance. Nateglinide dosage: unknown. During the same period patient was treated with VALSARTAN. Patient was hospitalized. Patient recovered.

Nateglinide Side Effects Report #5611241-X
Nateglinide side effect was reported by a Physician from SPAIN on Jan 23, 2008. Male patient, 88 years of age, weighting 130.1 lb, was diagnosed with glucose tolerance impaired, cardiovascular disorder and was treated with Nateglinide. After drug was administered, patient experienced the following side effects: blood sodium decreased, electrolyte imbalance. Nateglinide dosage: unknown. During the same period patient was treated with VALSARTAN. Patient was hospitalized. Patient recovered.

Nateglinide Side Effects Report #5669714-X
Nateglinide side effect was reported by a Physician from SPAIN on Mar 05, 2008. Male patient, 88 years of age, weighting 130.1 lb, was diagnosed with glucose tolerance impaired, cardiovascular disorder and was treated with Nateglinide. After drug was administered, patient experienced the following side effects: asthenia, blood potassium increased, blood sodium decreased, electrolyte imbalance, gait disturbance, hyponatraemia, polyuria, vomiting. Nateglinide dosage: unknown. During the same period patient was treated with VALSARTAN. Patient was hospitalized. Patient recovered.